SIMILAR PATTERNS OF AMINO ACIDS FOR 4QRC_A_0LIA802_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1coy CHOLESTEROL OXIDASE

(Brevibacterium
sterolicum)
PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C)
5 ALA A  27
LEU A 298
ALA A 288
ASP A 474
LEU A 477
None
None
None
FAD  A 510 (-4.7A)
None
1.11A 4qrcA-1coyA:
undetectable
4qrcA-1coyA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jr1 INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE 2


(Cricetulus
griseus)
PF00478
(IMPDH)
PF00571
(CBS)
5 ALA A 248
MET A 290
VAL A 271
ALA A 264
ASP A 261
None
1.07A 4qrcA-1jr1A:
undetectable
4qrcA-1jr1A:
21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k9a CARBOXYL-TERMINAL
SRC KINASE


(Rattus
norvegicus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
5 ALA A 220
GLU A 236
MET A 240
LEU A 305
ARG A 313
None
0.72A 4qrcA-1k9aA:
31.3
4qrcA-1k9aA:
30.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o8c YHDH

(Escherichia
coli)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 ALA A 176
VAL A 152
LEU A 282
ALA A 165
LEU A 170
None
1.13A 4qrcA-1o8cA:
undetectable
4qrcA-1o8cA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Mus musculus)
PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr)
6 ALA A 288
GLU A 305
MET A 309
LEU A 373
ARG A 381
ALA A 399
P16  A   2 (-3.4A)
P16  A   2 (-4.2A)
P16  A   2 (-3.3A)
None
None
P16  A   2 (-3.5A)
0.83A 4qrcA-1opkA:
30.7
4qrcA-1opkA:
29.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1py5 TGF-BETA RECEPTOR
TYPE I


(Homo sapiens)
PF00069
(Pkinase)
PF08515
(TGF_beta_GS)
5 ALA A 230
GLU A 245
LEU A 316
ARG A 332
ALA A 350
PY1  A 700 (-3.5A)
PY1  A 700 ( 4.9A)
None
None
PY1  A 700 ( 4.2A)
0.59A 4qrcA-1py5A:
26.1
4qrcA-1py5A:
27.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqy ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 1
ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 2


(Streptomyces
coelicolor)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 ALA B  75
GLU B 229
VAL B 187
LEU A 143
LEU B 191
None
1.15A 4qrcA-1tqyB:
undetectable
4qrcA-1tqyB:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ujn DEHYDROQUINATE
SYNTHASE


(Thermus
thermophilus)
PF01761
(DHQ_synthase)
6 ALA A 208
VAL A 209
LEU A 255
ARG A 276
ALA A 174
LEU A 187
None
1.27A 4qrcA-1ujnA:
undetectable
4qrcA-1ujnA:
24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v71 HYPOTHETICAL PROTEIN
C320.14 IN
CHROMOSOME III


(Schizosaccharomyces
pombe)
PF00291
(PALP)
5 ALA A  16
GLU A 170
VAL A  13
LEU A 178
ALA A 164
None
1.15A 4qrcA-1v71A:
undetectable
4qrcA-1v71A:
20.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA X  37
GLU X  54
MET X  58
ARG X 129
ALA X 147
STU  X 902 (-3.1A)
STU  X 902 ( 4.4A)
None
PTR  X 160 ( 3.4A)
STU  X 902 ( 4.1A)
0.70A 4qrcA-2dq7X:
31.7
4qrcA-2dq7X:
34.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 271
GLU A 288
MET A 292
ARG A 363
ALA A 381
ASP A 382
1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
1.37A 4qrcA-2hk5A:
31.2
4qrcA-2hk5A:
39.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 269
GLU A 286
MET A 290
ARG A 362
ALA A 380
ASP A 381
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
None
GIN  A 600 (-3.1A)
GIN  A 600 (-4.9A)
1.09A 4qrcA-2hz0A:
31.7
4qrcA-2hz0A:
40.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 269
GLU A 286
MET A 290
LEU A 354
ARG A 362
ALA A 380
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
GIN  A 600 ( 4.6A)
None
GIN  A 600 (-3.1A)
0.82A 4qrcA-2hz0A:
31.7
4qrcA-2hz0A:
40.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 271
ARG A 363
ALA A 381
ASP A 382
PHE A 383
1N8  A 501 ( 3.4A)
None
1N8  A 501 ( 3.3A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 4.3A)
1.16A 4qrcA-2og8A:
31.4
4qrcA-2og8A:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 271
GLU A 288
MET A 292
ALA A 381
ASP A 382
PHE A 383
1N8  A 501 ( 3.4A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 4.3A)
0.94A 4qrcA-2og8A:
31.4
4qrcA-2og8A:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 614
GLU A 633
MET A 637
LEU A 769
CYH A 774
ARG A 777
None
0.69A 4qrcA-2ogvA:
33.3
4qrcA-2ogvA:
45.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 853
ARG A 963
ALA A 981
ASP A 982
PHE A 983
MR9  A 301 (-3.5A)
None
MR9  A 301 (-3.2A)
MR9  A 301 (-4.2A)
MR9  A 301 (-4.4A)
1.11A 4qrcA-2p4iA:
27.9
4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 853
LEU A 955
ARG A 963
ALA A 981
PHE A 983
MR9  A 301 (-3.5A)
MR9  A 301 (-4.4A)
None
MR9  A 301 (-3.2A)
MR9  A 301 (-4.4A)
0.68A 4qrcA-2p4iA:
27.9
4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 ALA A 515
GLU A 534
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
ALA A 643
None
None
None
None
None
None
SO4  A 303 ( 2.9A)
None
0.70A 4qrcA-2psqA:
36.4
4qrcA-2psqA:
66.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r2p EPHRIN TYPE-A
RECEPTOR 5


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
5 ALA A 705
GLU A 724
MET A 728
LEU A 791
ARG A 799
None
None
None
None
SO4  A   1 ( 3.1A)
1.08A 4qrcA-2r2pA:
32.2
4qrcA-2r2pA:
32.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xik SERINE/THREONINE
PROTEIN KINASE 25


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  47
GLU A  66
LEU A 131
ARG A 139
ALA A 157
J60  A1294 (-3.3A)
None
None
TPO  A 174 ( 2.9A)
J60  A1294 ( 4.2A)
0.85A 4qrcA-2xikA:
18.7
4qrcA-2xikA:
26.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A1028
GLU A1047
MET A1051
LEU A1123
ARG A1131
S91  A   1 (-3.2A)
None
None
None
PTR  A1163 ( 3.6A)
0.99A 4qrcA-2z8cA:
31.4
4qrcA-2z8cA:
37.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ayf NITRIC OXIDE
REDUCTASE


(Geobacillus
stearothermophilus)
PF00115
(COX1)
5 ALA A 375
VAL A 456
ALA A 477
PHE A 518
LEU A 472
None
0.94A 4qrcA-3ayfA:
undetectable
4qrcA-3ayfA:
18.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 515
GLU A 534
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
M33  A1996 (-3.3A)
None
None
None
None
None
None
0.96A 4qrcA-3b2tA:
27.8
4qrcA-3b2tA:
74.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 515
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
ALA A 643
M33  A1996 (-3.3A)
None
None
None
None
None
None
0.80A 4qrcA-3b2tA:
27.8
4qrcA-3b2tA:
74.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c1x HEPATOCYTE GROWTH
FACTOR RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 GLU A1127
MET A1131
LEU A1195
ALA A1221
ASP A1222
CKK  A1500 (-3.4A)
CKK  A1500 (-3.4A)
CKK  A1500 (-4.4A)
CKK  A1500 (-3.4A)
CKK  A1500 (-4.5A)
1.16A 4qrcA-3c1xA:
24.4
4qrcA-3c1xA:
32.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
ARG A 622
ALA A 640
C4F  A   1 (-3.3A)
None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
0.92A 4qrcA-3c4fA:
40.3
4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ALA A 640
C4F  A   1 (-3.3A)
None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
0.46A 4qrcA-3c4fA:
40.3
4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 GLU A 531
MET A 535
VAL A 561
LEU A 614
ARG A 622
ALA A 640
PHE A 489
None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
C4F  A   1 (-3.7A)
1.18A 4qrcA-3c4fA:
40.3
4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 220
GLU A 236
MET A 240
LEU A 305
ARG A 313
None
0.72A 4qrcA-3d7uA:
25.5
4qrcA-3d7uA:
40.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dko EPHRIN TYPE-A
RECEPTOR 7


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
5 ALA A 663
GLU A 682
MET A 686
LEU A 749
PHE A 777
IHZ  A1001 (-3.3A)
IHZ  A1001 (-3.8A)
IHZ  A1001 (-3.5A)
None
IHZ  A1001 (-4.7A)
0.80A 4qrcA-3dkoA:
31.7
4qrcA-3dkoA:
32.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h7v O-SUCCINYLBENZOATE
SYNTHASE


(Thermosynechococcus
elongatus)
PF13378
(MR_MLE_C)
5 ALA A 271
GLU A  54
CYH A  63
PHE A  87
LEU A  82
None
1.15A 4qrcA-3h7vA:
undetectable
4qrcA-3h7vA:
21.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 859
GLU A 878
VAL A 909
ARG A1021
ASP A1040
8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
None
None
1.04A 4qrcA-3hngA:
35.1
4qrcA-3hngA:
45.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 859
GLU A 878
VAL A 909
ARG A1021
PHE A1041
8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
None
8ST  A2001 ( 3.7A)
1.01A 4qrcA-3hngA:
35.1
4qrcA-3hngA:
45.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 859
GLU A 878
VAL A 909
LEU A1013
CYH A1018
ARG A1021
8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
8ST  A2001 (-4.6A)
8ST  A2001 ( 4.7A)
None
0.73A 4qrcA-3hngA:
35.1
4qrcA-3hngA:
45.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hu5 ISOCHORISMATASE
FAMILY PROTEIN


(Desulfovibrio
vulgaris)
PF00857
(Isochorismatase)
5 ALA A  12
VAL A 131
ALA A 147
ASP A 146
PHE A 112
None
1.02A 4qrcA-3hu5A:
undetectable
4qrcA-3hu5A:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k11 PUTATIVE GLYCOSYL
HYDROLASE


(Bacteroides
thetaiotaomicron)
PF07470
(Glyco_hydro_88)
5 ALA A 382
VAL A 381
LEU A 293
ALA A 426
LEU A 356
None
1.18A 4qrcA-3k11A:
undetectable
4qrcA-3k11A:
21.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3kul EPHRIN TYPE-A
RECEPTOR 8


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM)
5 ALA A 665
GLU A 684
MET A 688
LEU A 751
ARG A 759
None
0.96A 4qrcA-3kulA:
32.7
4qrcA-3kulA:
34.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS)
5 ALA A 229
GLU A 244
LEU A 315
ARG A 331
ALA A 349
LDN  A   1 (-3.6A)
None
None
None
LDN  A   1 ( 3.8A)
0.90A 4qrcA-3mdyA:
25.9
4qrcA-3mdyA:
29.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n54 SPORE GERMINATION
PROTEIN B3


(Bacillus
subtilis)
PF05504
(Spore_GerAC)
5 ALA B 201
VAL B 140
LEU B 216
ALA B 193
LEU B 130
None
1.13A 4qrcA-3n54B:
undetectable
4qrcA-3n54B:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nng UNCHARACTERIZED
PROTEIN


(Bacteroides
fragilis)
PF00754
(F5_F8_type_C)
5 ALA A 216
VAL A 201
CYH A 203
LEU A 251
PHE A 328
None
1.10A 4qrcA-3nngA:
undetectable
4qrcA-3nngA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 109
GLU A 130
MET A 134
ARG A 204
ASP A 223
JOZ  A 361 (-3.4A)
SO4  A   5 (-3.1A)
None
SEP  A 241 ( 3.4A)
SO4  A   5 ( 4.5A)
1.13A 4qrcA-3nuuA:
24.1
4qrcA-3nuuA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 109
GLU A 130
MET A 134
LEU A 196
ARG A 204
JOZ  A 361 (-3.4A)
SO4  A   5 (-3.1A)
None
None
SEP  A 241 ( 3.4A)
0.80A 4qrcA-3nuuA:
24.1
4qrcA-3nuuA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nx4 PUTATIVE
OXIDOREDUCTASE


(Salmonella
enterica)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
5 ALA A 176
VAL A 152
LEU A 282
ALA A 165
LEU A 170
None
1.12A 4qrcA-3nx4A:
undetectable
4qrcA-3nx4A:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pfq PROTEIN KINASE C
BETA TYPE


(Rattus
norvegicus)
PF00069
(Pkinase)
PF00130
(C1_1)
PF00168
(C2)
PF00433
(Pkinase_C)
5 ALA A 369
GLU A 390
LEU A 457
ARG A 465
ALA A 483
ANP  A 800 (-3.6A)
None
None
TPO  A 500 ( 2.9A)
ANP  A 800 ( 3.8A)
1.14A 4qrcA-3pfqA:
16.5
4qrcA-3pfqA:
19.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ppz SERINE/THREONINE-PRO
TEIN KINASE CTR1


(Arabidopsis
thaliana)
PF07714
(Pkinase_Tyr)
5 ALA A 576
GLU A 596
MET A 600
LEU A 665
ARG A 675
STU  A   1 (-3.3A)
None
None
None
SEP  A 710 ( 3.6A)
1.02A 4qrcA-3ppzA:
29.1
4qrcA-3ppzA:
33.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4t ACTIVIN RECEPTOR
TYPE-2A


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 217
GLU A 232
LEU A 303
ARG A 321
ALA A 339
TAK  A   2 (-3.5A)
TAK  A   2 ( 4.9A)
None
None
TAK  A   2 ( 4.2A)
1.12A 4qrcA-3q4tA:
24.7
4qrcA-3q4tA:
28.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s95 LIM DOMAIN KINASE 1

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 GLU A 384
MET A 388
LEU A 451
ARG A 459
ALA A 477
STU  A   1 (-3.7A)
None
None
None
STU  A   1 ( 4.1A)
1.02A 4qrcA-3s95A:
26.1
4qrcA-3s95A:
29.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  71
GLU A  84
CYH A 120
LEU A 157
ARG A 165
I85  A 350 (-3.3A)
None
I85  A 350 ( 3.8A)
None
None
0.95A 4qrcA-3sheA:
12.9
4qrcA-3sheA:
25.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ARG A 622
ALA A 640
07J  A   1 (-3.5A)
07J  A   1 (-3.8A)
07J  A   1 (-3.8A)
07J  A   1 (-4.7A)
None
None
None
07J  A   1 (-3.2A)
0.63A 4qrcA-3tt0A:
39.4
4qrcA-3tt0A:
67.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 GLU A 531
MET A 535
VAL A 561
ARG A 622
ALA A 640
ASP A 641
07J  A   1 (-3.8A)
07J  A   1 (-3.8A)
07J  A   1 (-4.7A)
None
07J  A   1 (-3.2A)
07J  A   1 (-4.7A)
1.36A 4qrcA-3tt0A:
39.4
4qrcA-3tt0A:
67.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3txo PROTEIN KINASE C ETA
TYPE


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
5 ALA A 382
GLU A 403
LEU A 470
ARG A 478
ALA A 496
07U  A   1 (-3.3A)
07U  A   1 ( 4.8A)
None
None
07U  A   1 ( 4.0A)
1.05A 4qrcA-3txoA:
14.0
4qrcA-3txoA:
24.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
CYH A1024
ARG A1027
4TT  A2001 (-3.5A)
None
None
None
None
1.16A 4qrcA-3vidA:
35.1
4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
ASP A1046
4TT  A2001 (-3.5A)
None
None
None
None
0.88A 4qrcA-3vidA:
35.1
4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
4TT  A2001 (-3.5A)
None
None
None
None
0.76A 4qrcA-3vidA:
35.1
4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
LEV  A1201 (-3.5A)
LEV  A1201 (-3.7A)
LEV  A1201 ( 4.6A)
None
DTT  A1202 (-2.0A)
0.49A 4qrcA-3wzdA:
28.9
4qrcA-3wzdA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a5o BIFUNCTIONAL PROTEIN
FOLD


(Pseudomonas
aeruginosa)
PF00763
(THF_DHG_CYH)
PF02882
(THF_DHG_CYH_C)
5 ALA A  52
VAL A  51
LEU A  86
ALA A  67
LEU A  70
None
1.02A 4qrcA-4a5oA:
undetectable
4qrcA-4a5oA:
23.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
ARG A1027
LEU A 802
B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
1.02A 4qrcA-4agdA:
35.2
4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
ARG A1027
B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
0.91A 4qrcA-4agdA:
35.2
4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
0.87A 4qrcA-4agdA:
35.2
4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 653
GLU A 672
MET A 676
LEU A 757
ALA A 783
ASP A 784
PHE A 785
DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.4A)
DI1  A1000 (-3.7A)
DI1  A1000 (-4.1A)
DI1  A1000 (-4.5A)
1.11A 4qrcA-4ckrA:
31.1
4qrcA-4ckrA:
35.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 GLU A 672
MET A 676
LEU A 757
ARG A 765
ALA A 783
ASP A 784
PHE A 785
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.4A)
None
DI1  A1000 (-3.7A)
DI1  A1000 (-4.1A)
DI1  A1000 (-4.5A)
1.21A 4qrcA-4ckrA:
31.1
4qrcA-4ckrA:
35.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2


(Homo sapiens)
PF00069
(Pkinase)
PF00433
(Pkinase_C)
5 ALA A 684
GLU A 705
LEU A 773
ARG A 781
ALA A 799
AGS  A1985 (-3.5A)
None
None
TPO  A 816 ( 3.0A)
AGS  A1985 ( 4.5A)
0.86A 4qrcA-4crsA:
16.0
4qrcA-4crsA:
27.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4e93 TYROSINE-PROTEIN
KINASE FES/FPS


(Homo sapiens)
PF00017
(SH2)
PF07714
(Pkinase_Tyr)
5 ALA A 588
GLU A 607
LEU A 674
CYH A 679
ARG A 682
GUI  A 901 (-3.4A)
None
None
None
None
1.08A 4qrcA-4e93A:
32.2
4qrcA-4e93A:
33.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4f4p TYROSINE-PROTEIN
KINASE SYK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 400
GLU A 420
MET A 424
LEU A 485
ARG A 493
0SB  A 701 (-3.3A)
None
None
None
SO4  A 702 (-3.0A)
0.97A 4qrcA-4f4pA:
29.3
4qrcA-4f4pA:
37.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fr4 SERINE/THREONINE-PRO
TEIN KINASE 32A


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  50
GLU A  71
VAL A 100
LEU A 137
ARG A 145
STU  A 401 (-3.2A)
None
None
None
None
0.60A 4qrcA-4fr4A:
21.4
4qrcA-4fr4A:
21.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 853
GLU A 871
LEU A 940
CYH A 945
ARG A 948
ALA A 966
19S  A1201 (-3.3A)
None
None
None
None
19S  A1201 ( 4.1A)
0.98A 4qrcA-4hviA:
30.6
4qrcA-4hviA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 506
GLU A 525
MET A 529
VAL A 555
ARG A 616
ALA A 634
ASP A 635
ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
ACP  A 801 (-4.7A)
None
None
MG  A 802 ( 3.0A)
1.23A 4qrcA-4k33A:
29.6
4qrcA-4k33A:
77.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
7 ALA A 506
GLU A 525
MET A 529
VAL A 555
LEU A 608
ARG A 616
ALA A 634
ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
ACP  A 801 (-4.7A)
None
None
None
0.75A 4qrcA-4k33A:
29.6
4qrcA-4k33A:
77.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lg4 SERINE/THREONINE-PRO
TEIN KINASE 3


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  54
GLU A  70
MET A  74
LEU A 137
ALA A 163
GOL  A 404 ( 3.1A)
None
None
None
GOL  A 403 ( 3.0A)
0.99A 4qrcA-4lg4A:
20.1
4qrcA-4lg4A:
25.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mvf CALCIUM-DEPENDENT
PROTEIN KINASE 2


(Plasmodium
falciparum)
PF00069
(Pkinase)
PF13499
(EF-hand_7)
5 ALA A  99
GLU A 117
MET A 121
LEU A 183
ARG A 191
STU  A 601 (-3.3A)
None
None
None
None
0.83A 4qrcA-4mvfA:
15.2
4qrcA-4mvfA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24


(Homo sapiens)
PF00069
(Pkinase)
5 ALA B  51
GLU B  70
LEU B 135
ARG B 143
ALA B 161
ADP  B 500 (-3.3A)
None
None
None
None
0.82A 4qrcA-4o27B:
19.9
4qrcA-4o27B:
27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oav PROTEIN (RNASE L)

(Homo sapiens)
PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5)
5 ALA B 390
GLU B 404
VAL B 434
LEU B 475
ALA B 502
ACP  B 801 (-3.2A)
None
ACP  B 801 (-4.8A)
None
None
0.99A 4qrcA-4oavB:
17.7
4qrcA-4oavB:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opf NRPS/PKS

(Streptomyces
albus)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 ALA A6338
LEU A6344
ARG A6465
ALA A6455
LEU A6138
None
1.16A 4qrcA-4opfA:
undetectable
4qrcA-4opfA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pxn UNCHARACTERIZED
PROTEIN


(Zea mays)
PF00171
(Aldedh)
5 ALA A 170
VAL A 171
CYH A 169
ALA A 164
LEU A 268
None
None
None
NAD  A 601 (-3.3A)
None
1.17A 4qrcA-4pxnA:
undetectable
4qrcA-4pxnA:
25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 642
GLU A 661
LEU A 802
CYH A 807
ARG A 810
P30  A1001 (-3.4A)
P30  A1001 (-3.6A)
None
None
None
1.01A 4qrcA-4rt7A:
28.4
4qrcA-4rt7A:
40.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tpt LIM DOMAIN KINASE 2

(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 LEU A 442
ARG A 450
ALA A 468
ASP A 469
PHE A 470
35H  A 701 ( 4.7A)
None
35H  A 701 (-3.5A)
35H  A 701 (-4.7A)
35H  A 701 (-4.4A)
0.83A 4qrcA-4tptA:
21.7
4qrcA-4tptA:
29.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL


(synthetic
construct)
PF07714
(Pkinase_Tyr)
5 ALA A  35
GLU A  52
MET A  56
LEU A 120
ALA A 146
ACP  A1264 (-2.9A)
None
None
None
None
1.02A 4qrcA-4ueuA:
30.9
4qrcA-4ueuA:
39.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  72
GLU A  90
MET A  94
LEU A 165
ARG A 175
KSA  A 405 (-3.2A)
None
None
None
None
0.82A 4qrcA-4wsqA:
22.9
4qrcA-4wsqA:
24.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 ALA A 501
GLU A 520
MET A 524
VAL A 550
CYH A 552
LEU A 603
CYH A 608
ALA A 629
40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
40M  A1002 (-4.7A)
40M  A1002 (-1.8A)
None
None
40M  A1002 (-3.0A)
0.32A 4qrcA-4xcuA:
39.0
4qrcA-4xcuA:
90.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4


(Homo sapiens)
PF07714
(Pkinase_Tyr)
6 ALA A 501
GLU A 520
MET A 524
VAL A 550
LEU A 603
LEU A 633
40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
40M  A1002 (-4.7A)
None
None
1.30A 4qrcA-4xcuA:
39.0
4qrcA-4xcuA:
90.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 642
GLU A 661
ARG A 810
ASP A 829
PHE A 830
P30  A1001 (-3.5A)
P30  A1001 (-3.1A)
None
None
P30  A1001 ( 4.1A)
1.11A 4qrcA-4xufA:
33.7
4qrcA-4xufA:
47.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 642
GLU A 661
LEU A 802
ARG A 810
PHE A 830
P30  A1001 (-3.5A)
P30  A1001 (-3.1A)
None
None
P30  A1001 ( 4.1A)
1.01A 4qrcA-4xufA:
33.7
4qrcA-4xufA:
47.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5a46 FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B


(Homo sapiens)
PF07714
(Pkinase_Tyr)
8 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ARG A 622
ALA A 640
38O  A1769 (-3.6A)
EDO  A1766 (-4.1A)
EDO  A1766 (-3.5A)
38O  A1769 (-4.3A)
None
None
None
EDO  A1766 ( 4.4A)
0.76A 4qrcA-5a46A:
40.3
4qrcA-5a46A:
64.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a8f HUMAN SAFFOLD
VIRUS-3 VP2


(Cardiovirus B)
PF00073
(Rhv)
5 ALA C  87
VAL C  82
LEU C 198
ALA C 251
LEU C 208
None
1.16A 4qrcA-5a8fC:
undetectable
4qrcA-5a8fC:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ci7 SERINE/THREONINE-PRO
TEIN KINASE ULK1


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  44
GLU A  63
LEU A 129
ARG A 137
ALA A 164
51W  A 401 (-3.4A)
None
None
TPO  A 180 ( 2.9A)
None
1.11A 4qrcA-5ci7A:
19.0
4qrcA-5ci7A:
27.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e4y HOMOSERINE
O-ACETYLTRANSFERASE


(Pseudomonas
veronii)
PF00561
(Abhydrolase_1)
5 ALA A 160
VAL A 136
ALA A  73
ASP A 337
LEU A 333
None
0.94A 4qrcA-5e4yA:
undetectable
4qrcA-5e4yA:
23.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fm2 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 756
GLU A 775
VAL A 804
LEU A 865
ARG A 873
PP1  A2012 (-3.2A)
PP1  A2012 (-3.5A)
PP1  A2012 (-4.5A)
None
SEP  A 909 ( 3.0A)
1.01A 4qrcA-5fm2A:
34.7
4qrcA-5fm2A:
48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 625
GLU A 644
MET A 648
LEU A 809
CYH A 814
748  A1001 (-3.7A)
748  A1001 (-3.3A)
748  A1001 (-3.4A)
748  A1001 ( 4.6A)
748  A1001 (-3.4A)
0.46A 4qrcA-5grnA:
26.2
4qrcA-5grnA:
44.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hor HEPATOCYTE GROWTH
FACTOR RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A1108
MET A1131
LEU A1195
ARG A1203
ALA A1221
63K  A1401 (-3.5A)
None
None
None
63K  A1401 (-3.3A)
1.05A 4qrcA-5horA:
24.7
4qrcA-5horA:
32.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5idn CYCLIN-DEPENDENT
KINASE 8


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  50
GLU A  66
LEU A 142
ARG A 150
ALA A 172
6A7  A 401 (-3.3A)
FMT  A 404 ( 4.2A)
None
None
6A7  A 401 ( 4.1A)
0.95A 4qrcA-5idnA:
15.9
4qrcA-5idnA:
23.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A  43
GLU A  61
MET A  65
LEU A 127
ALA A 153
6G2  A 901 (-3.2A)
None
None
None
6G2  A 901 ( 4.2A)
0.80A 4qrcA-5j5tA:
22.2
4qrcA-5j5tA:
23.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j9z EPIDERMAL GROWTH
FACTOR RECEPTOR


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ALA A 743
GLU A 762
MET A 766
LEU A 828
ARG A 836
6HJ  A1101 (-3.1A)
6HJ  A1101 ( 4.2A)
6HJ  A1101 ( 4.1A)
None
None
1.04A 4qrcA-5j9zA:
30.8
4qrcA-5j9zA:
32.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1


(Homo sapiens)
PF00069
(Pkinase)
5 ALA A 297
GLU A 315
MET A 319
LEU A 380
ARG A 388
IPW  A 601 (-3.5A)
IPW  A 601 (-3.9A)
IPW  A 601 (-4.1A)
None
None
0.88A 4qrcA-5kbrA:
22.3
4qrcA-5kbrA:
27.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l7n PLEXIN-A1

(Mus musculus)
PF01833
(TIG)
5 ALA A 925
VAL A 903
LEU A 949
ALA A 933
LEU A 867
None
1.12A 4qrcA-5l7nA:
undetectable
4qrcA-5l7nA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ul4 OXSB PROTEIN

(Bacillus
megaterium)
PF02310
(B12-binding)
5 GLU A 364
CYH A 318
ARG A 317
ALA A 400
ASP A 401
None
SF4  A 801 (-2.2A)
None
None
None
1.13A 4qrcA-5ul4A:
undetectable
4qrcA-5ul4A:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1


(Homo sapiens)
no annotation 5 ALA A 388
GLU A 409
MET A 413
LEU A 475
ARG A 483
EE4  A 701 (-3.3A)
DMS  A 702 ( 4.2A)
None
None
TPO  A 517 ( 3.0A)
1.05A 4qrcA-6c0tA:
16.3
4qrcA-6c0tA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c9d SERINE/THREONINE-PRO
TEIN KINASE
MARK1,SERINE/THREONI
NE-PROTEIN KINASE
MARK1


(Homo sapiens)
no annotation 5 ALA A  87
GLU A 107
MET A 111
ARG A 181
ALA A 199
None
0.75A 4qrcA-6c9dA:
22.4
4qrcA-6c9dA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f5d ATP SYNTHASE ALPHA
CHAIN, MITOCHONDRIAL
ATP SYNTHASE SUBUNIT
BETA


(Trypanosoma
brucei)
no annotation 5 VAL D 317
LEU D 294
ARG A 222
ALA D 328
LEU D 334
None
1.07A 4qrcA-6f5dD:
undetectable
4qrcA-6f5dD:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fek PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET


(Homo sapiens)
no annotation 5 ALA A 756
GLU A 775
VAL A 804
LEU A 865
ARG A 873
ADN  A1104 (-3.4A)
None
ADN  A1104 ( 4.6A)
None
FMT  A1101 (-2.8A)
1.05A 4qrcA-6fekA:
34.4
4qrcA-6fekA:
25.13